COMMUNIQUÉS West-GlobeNewswire

Reminder: Investor Conference Call Today July 25, 2019 Management to Provide Details on Generex Up-list and 1:1 Stock Dividend
25/07/2019
MIRAMAR, Fla., July 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access information for its [...]
Acer Therapeutics to Host Conference Call and Webcast to Discuss Update on its Pipeline Programs
25/07/2019
Call to take place on Wednesday, July 31 at 11:00 am Eastern Time NEWTON, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development [...]
Progenics Pharmaceuticals Announces Collaboration with Veterans Affairs on the AI Research Program for Medical Image Analysis
25/07/2019
The collaboration with VA Greater Los Angeles Healthcare System is nation’s first to validate deep learning algorithms in medical imaging of veterans with prostate cancer NEW YORK and WASHINGTON, July 25, 2019 (GLOBE [...]
Driven Deliveries Inc. Partners with Mozen, to provide Direct to Consumer Cannabis Delivery Service
25/07/2019
The Company continues to expand direct to consumer business SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Driven, the online cannabis sales platform, marketing and home delivery leader announced today that it has [...]
Bill W. Colston Named to Fluidigm Board of Directors
25/07/2019
Senior Biotechnology Leader with Broad Expertise in Life Science and Digital Health SOUTH SAN FRANCISCO, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of [...]
Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors
25/07/2019
SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced the appointment of Carol [...]
The Joint Corp. to Host Conference Call on Thursday, August 8 to Discuss Second Quarter 2019 Results
25/07/2019
SCOTTSDALE, Ariz., July 25, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its second quarter 2019 financial [...]
EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019
25/07/2019
45% growth in total Q2 2019 revenue year-over-year 78% growth in HIFU sales year-to-date through June 30, 2019 Company to Report Second Quarter 2019 Financial Results on Wednesday, August 28, 2019 and to host conference [...]
Geron to Announce Second Quarter Financial Results on August 1, 2019
25/07/2019
MENLO PARK, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2019 financial results after the market closes on Thursday, August 1, 2019 [...]
Dermatology Experts Present Latest Information at 2019 AAD Summer Meeting
25/07/2019
NEW YORK, July 25, 2019 (GLOBE NEWSWIRE) -- The 2019 American Academy of Dermatology Summer Meeting will take place from July 25 to 28 at the New York Hilton Midtown. The meeting will feature the latest information on [...]
Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy
25/07/2019
CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Passage Bio Expands Executive Management Team
25/07/2019
Company appoints Jill Quigley, J.D., as Chief Operating Officer and Alex Fotopoulos as Chief Technical Officer PHILADELPHIA, July 25, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV- [...]
Tabula Rasa HealthCare Executive to Present at EXPO.health 2019
25/07/2019
Dr. Alan Stein to Speak on Using Data Science to Mitigate Medication Risk MOORESTOWN, N.J., July 25, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (NASDAQ: TRHC), a healthcare technology company advancing the field of [...]
Evelo Biosciences Secures $45 Million Debt Financing from K2 HealthVentures
25/07/2019
CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects, [...]
HTG Molecular to Present Corporate Overview at the Canaccord Genuity 39th Annual Growth Conference
25/07/2019
TUCSON, Ariz., July 25, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski, [...]
Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS
25/07/2019
- Compelling data reported with ADP-A2M4 SPEAR T-cells in synovial sarcoma - - Adaptimmune plans to launch a TCR T-cell therapy in 2022 - PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 25, 2019 (GLOBE NEWSWIRE) -- [...]
Soleno Therapeutics Provides Update on Ongoing DESTINY PWS Phase III Trial of DCCR in Prader-Willi Syndrome
25/07/2019
REDWOOD CITY, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO, the Company or Soleno), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare [...]
Harrow Health to Announce Second Quarter 2019 Financial Results on August 14, 2019
25/07/2019
NASHVILLE, Tenn., July 25, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release second quarter 2019 financial results after the close of trading on Wednesday, August 14, 2019. The [...]
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2019 Earnings and Company Update
25/07/2019
CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]

Pages